David is a chartered accountant and holds a Master of Accounting from the University College Dublin, Ireland, and a Master of Business Administration from INSEAD, France. He serves as a Director of Headway Ireland Limited located in Ireland, which provides support and services to people with brain injuries.
David Brabazon, co-founder of Adapt Pharma, serves as Chief Financial Officer and a member of the Board of Directors. David was co-founder of Azur Pharma and served as its Chief Financial Officer. When Azur Pharma merged with Jazz Pharmaceuticals plc in 2012, David continued as Senior Vice President of Finance and Secretary until late 2012. Prior to his work at Azur, David served as President of Finance and Group Financial Controller of Élan Corporation, with responsibility for financial control, taxation, and treasury.